1. Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer 
Shawn S. Groth, MD, MS, Natasha M. Rueth, MD, James S. Hodges, PhD, Elizabeth B. Habermann, PhD, MPH, Rafael S. Andrade, MD, Jonathan D'Cunha, MD, PhD, Michael A. Maddaus, MD 
The Annals of Thoracic Surgery 
Volume 90, Issue 2, Pages (August 2010)
DOI: /j.athoracsur
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Cancer-specific survival curve (solid line) for patients with early stage (I and II) non-small cell lung cancer. (A) Representative (dotted) tangent lines demonstrate that the risk of death (slope of the curve) changes throughout the course of follow-up. (B) For example, the risk of dying of cancer in the subsequent 5 years is greater for patients at the time of cancer diagnosis (Δ1) than for patients 3 years after diagnosis (Δ2). Data from the Surveillance, Epidemiology, and End Results Database (1988–2005).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Patients included in and excluded from the study. (NSCLC = non-small cell lung cancer; SEER = Surveillance, Epidemiology, and End Results.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Five-year cancer-specific survival rates, with error bars indicating 95% confidence intervals (vertical axis) conditioned on surviving 0 to 10 years after lobectomy (horizontal axis).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

5. Fig 4
Competing risks curves for the probability of the following outcomes: surviving (solid line), cancer-specific mortality (dotted line), cardiovascular disease-specific mortality (dashed line), and death from other causes (dotted and dashed line) at (A) the time of diagnosis and conditioned on living (B) 1 year, (C) 3 years, (D) 5 years, and (E) 7 years after lobectomy. The p values are for tests comparing the conditional probabilities of cancer-specific and cardiovascular disease-specific mortality within 5 years.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

6. Fig 5
Analysis demonstrating the year at which the probability (P) of dying of cancer is not significantly different (p > 0.01) from the probability of dying of cardiovascular (CV) disease (vertical axis) for each of the following subgroups: (A) age, (B) race, (C) sex, (D) pathologic tumor (T) stage, and (E) histology. (Adeno = adenocarcinoma; BAC = bronchoalveolar carcinoma; squam = squamous cell carcinoma.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions